294 / 510
Cuidados
Continuos
293
BIBLIOGRAFÍA:
Nguyen T, DeAngelis LM. Treatment of Brain Metastases. J Support Oncol 2004; 2: 405–416.
Lassman AB, DeAngelis LM. Brain metastases. Neurol Clin 2003;21:1–23.
Counsell C, Grant R. Incidence studies of primary and secondary intracranial tumors: A systematic
review of their methodology and results. Journal of Neuro-oncology 1998; 37: 241-250.
Patchell RA. The management of brain metastases. Cancer Treatment Reviews 2003; 29: 533–540.
Abrey LE, Mason WP. Brain metastases. En: Abrey LE, Mason WP, eds. Brain Tumors. Oxford:
Health Press Limited, 2003; 48-55.
Tsao MN, Sultanem K, Chiu D, Copps F, Dixon P, Easton D, Haddad P, Hayter C, Hoegler D,
Wong R. Supportive care management of brain metastases: what is known and what we need
to know. Clin Oncol. 2003;15:429-34.
Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol.
1988;45(7):741.
Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T et al. Recursive partitioning
analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain
metastases trials. Int J Radiat Oncol Biol Phys. 1997; 37: 745-751.
Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis
(RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000; 47: 1001-1006.
NCCN guidelines
http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site(Acceso: 31 Marzo 2014).
Postmus PE, Haaxma-Reiche H, Smit EF, Groen HJ, Karnicka H, Lewinski T et al. Treatment
of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with
whole-brain radiotherapy-- a phase III study of the European Organization for the Research
and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol. 2000; 18: 3400-3408.
Mornex F, Thomas L, Mohr P, Hauschild A, Delaunay MM, Lesimple T et al. Randomised phase
III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases
of melanoma. Cancer Radiother. 2003; 7: 1-8.
Antonadou D, Paraskevaidis M, Sarris G, Coliarakis N, Economou I, Karageorgis P et al.
Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain
metastases. J Clin Oncol. 2002; 20: 3644-3650.
Bachelot T , Romieu G, Campone M, Diéras V, Cropet C, Dalenc F, et al. Lapatinib plus
capecitabine in patients with previously untreated brain metastases from HER2-positive
metastatic breast cancer (LANDSCAPE): a single-group phase 2 study. Lancet Oncol. 2013
Jan;14(1):64-71.
Porta R., Sánchez-Torres J.M., Paz-Ares L., Massutí B., Reguart N.,. Mayo C,et al.
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation.
Eur Respir J 2011; 37: 624–631.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.